Bringing Kanzius cancer research to DC

November 13, 2013

WASHINGTON, D.C. – It’s not everyday someone from Northwest Pennsylvania gets to meet face-to-face with a U.S. Senator –let alone two. But Wednesday, Mark Neidig did just that.

Neidig came to our nation’s capital to tell the senators about the Kanzius Cancer Research Foundation’s progress. Their GenV machine killed 100% of liver cancer in pigs, without side-effects. Researchers are now putting together their findings to submit to the Food and Drug Administration.

“We don’t come asking for money. We know the government doesn’t have money. But, we do need support, we need advocacy, we need that awareness,” said Neidig.

And once they were aware of these early successes, both senators were pleased.

“I’m not surprised. Pennsylvania has always been a state – and Erie and Northwestern Pennsylvania – [that] has had a long tradition of discovery and scientific research leading to breakthroughs, and, hopefully someday, cures,” said Sen. Bob Casey (D-PA).

Sen. Pat Toomey (R-PA) said, “It’s just an amazing story about a guy, who, against all odds, came up with this therapy, and to see it make so much progress…[but] we’re not done yet. We still need successful clinical trials on human beings. That will be the next step.”

Neidig says Kanzius researchers hope to approach the FDA with their report early next year. Clinical trials could begin in 2015.

Leave a Reply